• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 98 of 100
Key Speakers At The Stanford Institute For Economic Policy Research Forum
LeadershipStep aside Wall Street, small pharma CEO pay reaches for the sky
By Paul HodgsonJanuary 5, 2015
Health workers in protective equipment handle a sample taken from the body of someone who is suspected to have died from Ebola virus, near Rokupa Hospital
FeaturesRoche wins FDA emergency approval for Ebola test
By Laura LorenzettiDecember 29, 2014
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
EyebrowRoche shares tumble after Alzheimer’s drug failure
By ReutersDecember 19, 2014
Inside Rite Aid Ahead of Earnings Reports
FeaturesRite Aid’s healthcare investments are paying off
By Laura LorenzettiDecember 18, 2014
FeaturesDrug-resistant infections could cost the global economy $100 trillion by 2050
By Laura LorenzettiDecember 12, 2014
Greg Wasson of Walgreen's in Chicago for Fotune 6-27-13
RetailWalgreen CEO to leave after Alliance Boots deal in reversal of plan
By Phil WahbaDecember 10, 2014
Valeant Offers to Buy Allergan With Pershing's Support
FinanceValeant puts dealmaking on hold to focus on the bottom line
By Laura LorenzettiDecember 9, 2014
FinanceMerck takes aim at superbugs with $9.5 billion deal for Cubist
By ReutersDecember 8, 2014
BRITAIN-PHARMACEUTICAL-GSK
EyebrowGSK cuts U.S. research and sales jobs as market gets tougher
By ReutersDecember 4, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
FeaturesJapan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
FinanceWynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
EyebrowAfter losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
FeaturesYour pharmacist called. You owe $1.3 trillion.
By Erika FryNovember 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
EyebrowPfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By Geoffrey SmithNovember 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.